These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Synthesis and pharmacological evaluation of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methylguanidines as N-methyl-D-aspartate receptor ion-channel blockers. Hu LY; Guo J; Magar SS; Fischer JB; Burke-Howie KJ; Durant GJ J Med Chem; 1997 Dec; 40(26):4281-9. PubMed ID: 9435897 [TBL] [Abstract][Full Text] [Related]
5. Use of trifluoroperazine isolates a [(3)H]Ifenprodil binding site in rat brain membranes with the pharmacology of the voltage-independent ifenprodil site on N-methyl-D-aspartate receptors containing NR2B subunits. Coughenour LL; Barr BM J Pharmacol Exp Ther; 2001 Jan; 296(1):150-9. PubMed ID: 11123375 [TBL] [Abstract][Full Text] [Related]
6. Discovery of novel and orally active NR2B-selective N-methyl-D-aspartate (NMDA) antagonists, pyridinol derivatives with reduced HERG binding affinity. Kawai M; Nakamura H; Sakurada I; Shimokawa H; Tanaka H; Matsumizu M; Ando K; Hattori K; Ohta A; Nukui S; Omura A; Kawamura M Bioorg Med Chem Lett; 2007 Oct; 17(20):5533-6. PubMed ID: 17768047 [TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors. Bettini E; Sava A; Griffante C; Carignani C; Buson A; Capelli AM; Negri M; Andreetta F; Senar-Sancho SA; Guiral L; Cardullo F J Pharmacol Exp Ther; 2010 Dec; 335(3):636-44. PubMed ID: 20810618 [TBL] [Abstract][Full Text] [Related]
9. Structural basis of NR2B-selective antagonist recognition by N-methyl-D-aspartate receptors. Mony L; Krzaczkowski L; Leonetti M; Le Goff A; Alarcon K; Neyton J; Bertrand HO; Acher F; Paoletti P Mol Pharmacol; 2009 Jan; 75(1):60-74. PubMed ID: 18923063 [TBL] [Abstract][Full Text] [Related]
10. Characterization of haloperidol and trifluperidol as subtype-selective N-methyl-D-aspartate (NMDA) receptor antagonists using [3H]TCP and [3H]ifenprodil binding in rat brain membranes. Coughenour LL; Cordon JJ J Pharmacol Exp Ther; 1997 Feb; 280(2):584-92. PubMed ID: 9023267 [TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships of alkyl- and alkoxy-substituted 1,4-dihydroquinoxaline-2,3-diones: potent and systemically active antagonists for the glycine site of the NMDA receptor. Cai SX; Kher SM; Zhou ZL; Ilyin V; Espitia SA; Tran M; Hawkinson JE; Woodward RM; Weber E; Keana JF J Med Chem; 1997 Feb; 40(5):730-8. PubMed ID: 9057859 [TBL] [Abstract][Full Text] [Related]
13. NMDA receptor antagonists augment antidepressant-like effects of lithium in the mouse forced swimming test. Ghasemi M; Raza M; Dehpour AR J Psychopharmacol; 2010 Apr; 24(4):585-94. PubMed ID: 19351802 [TBL] [Abstract][Full Text] [Related]
14. Nonopioid motor effects of dynorphin A and related peptides: structure dependence and role of the N-methyl-D-aspartate receptor. Shukla VK; Prasad JA; Lemaire S J Pharmacol Exp Ther; 1997 Nov; 283(2):604-10. PubMed ID: 9353375 [TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, and Biological Evaluation of 3-Benzazepin-1-ols as NR2B-Selective NMDA Receptor Antagonists. Tewes B; Frehland B; Schepmann D; Schmidtke KU; Winckler T; Wünsch B ChemMedChem; 2010 May; 5(5):687-95. PubMed ID: 20340125 [TBL] [Abstract][Full Text] [Related]
17. Novel structure having antagonist actions at both the glycine site of the N-methyl-D-aspartate receptor and neuronal voltage-sensitive sodium channels: biochemical, electrophysiological, and behavioral characterization. Snell LD; Claffey DJ; Ruth JA; Valenzuela CF; Cardoso R; Wang Z; Levinson SR; Sather WA; Williamson AV; Ingersoll NC; Ovchinnikova L; Bhave SV; Hoffman PL; Tabakoff B J Pharmacol Exp Ther; 2000 Jan; 292(1):215-27. PubMed ID: 10604951 [TBL] [Abstract][Full Text] [Related]
18. The improvement of the anti-hyperalgesic effect of ketamine and of its isomers by the administration of ifenprodil. Rondon ES; Vieira AS; Valadão CA; Parada CA Eur J Pharmacol; 2010 Nov; 647(1-3):84-9. PubMed ID: 20826141 [TBL] [Abstract][Full Text] [Related]
19. Development of 3-substituted-1H-indole derivatives as NR2B/NMDA receptor antagonists. Gitto R; De Luca L; Ferro S; Citraro R; De Sarro G; Costa L; Ciranna L; Chimirri A Bioorg Med Chem; 2009 Feb; 17(4):1640-7. PubMed ID: 19157884 [TBL] [Abstract][Full Text] [Related]
20. Antiparkinsonian actions of blockade of NR2B-containing NMDA receptors in the reserpine-treated rat. Nash JE; Hill MP; Brotchie JM Exp Neurol; 1999 Jan; 155(1):42-8. PubMed ID: 9918703 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]